Lifecore Biomedical, Inc. \De\
LFCR Nasdaq
SEC CIK 1005286
Follow Lifecore Biomedical, Inc. \De\
Weekly email: filings, results
Revenue, last quarter
$36.4M
−3.8% vs same quarter last year
Net income
−$1.1M
+83.8% vs same quarter last year
EPS, diluted
-
Operating cash flow
$5.3M
−38.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $128.9M | −$38.7M |
| FY24 | $128.3M | $12M |
| FY23 | $103.3M | −$99.6M |
| FY22 | $111.3M | −$116.7M |
| FY21 | $100.9M | −$32.3M |
| FY20 | $160.1M | −$38.2M |
| FY19 | $557.6M | $411K |
| FY18 | $524.2M | $24.8M |
| FY17 | $469.8M | $10.6M |
| FY16 | $476.9M | −$11.6M |
| FY15 | $539.3M | $13.5M |
| FY14 | $476.8M | $19.1M |
| FY13 | $441.7M | $22.6M |
| FY12 | $317.6M | $12.7M |
| FY11 | $276.7M | $3.9M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 31.3% | −13.4% | −30% |
| FY24 | 32.6% | −6.9% | 9.4% |
| FY23 | 27.1% | −21.1% | −96.4% |
| FY22 | 35.1% | −10.6% | −104.9% |
| FY21 | 38.6% | −8.7% | −32% |
| FY20 | 24.6% | −16.2% | −23.9% |
| FY19 | 14.5% | 1% | 0.1% |
| FY18 | 14.9% | 2.6% | 4.7% |
| FY17 | 16.9% | 3.1% | 2.3% |
| FY16 | 14% | −4.3% | −2.4% |
| FY15 | 12.1% | 3.4% | 2.5% |
| FY14 | 13.1% | 4.2% | 4% |
| FY13 | 14.2% | 5.6% | 5.1% |
| FY12 | 16.4% | 4.6% | 4% |
| FY11 | 16.9% | 2.9% | 1.4% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$13.6M |
| FY24 | −$18.1M |
| FY23 | - |
| FY22 | −$48.8M |
| FY21 | −$2.8M |
| FY20 | −$29.3M |
| FY19 | −$28.7M |
| FY18 | −$13.8M |
| FY17 | $6.8M |
| FY16 | −$18.9M |
| FY15 | $9.1M |
| FY14 | $6.2M |
| FY13 | $12.4M |
| FY12 | $16.8M |
| FY11 | $7.8M |
- Lifecore Biomedical, Inc. \De\
- Healthcare median
Show the numbers
| Year | Lifecore Biomedical, Inc. \De\ | Healthcare median |
|---|---|---|
| FY25 | −30% | −30.6% |
| FY24 | 9.4% | −47% |
| FY23 | −96.4% | −58% |
| FY22 | −104.9% | −80.4% |
| FY21 | −32% | −71.8% |
| FY20 | −23.9% | −62.2% |
| FY19 | 0.1% | −46.2% |
| FY18 | 4.7% | −49.6% |
| FY17 | 2.3% | −45.9% |
| FY16 | −2.4% | −36% |
| FY15 | 2.5% | −37.8% |
| FY14 | 4% | −35.5% |
| FY13 | 5.1% | −37.1% |
| FY12 | 4% | −29.1% |
| FY11 | 1.4% | −27.9% |